Bionano Genomics Stock Volume Indicators Chaikin AD Line

BNGO Stock  USD 0.24  0.01  4.00%   
Bionano Genomics volume indicators tool provides the execution environment for running the Chaikin AD Line indicator and other technical functions against Bionano Genomics. Bionano Genomics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of volume indicators indicators. As with most other technical indicators, the Chaikin AD Line indicator function is designed to identify and follow existing trends. Bionano Genomics volume indicators are based on Chaikin accumulation (buying pressure) and distribution (selling pressure) factors to determine the likely sustainability of a given price move.

Indicator
The output start index for this execution was zero with a total number of output elements of sixty-one. The Accumulation/Distribution line was developed by Marc Chaikin. It is interpreted by looking at a divergence in the direction of the indicator relative to Bionano Genomics price. If the Accumulation/Distribution Line is trending upward it indicates that the price may follow. If the Accumulation/Distribution Line becomes flat while Bionano Genomics price is still rising (or falling) then it signals a flattening of the price values.

Bionano Genomics Technical Analysis Modules

Most technical analysis of Bionano Genomics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Bionano from various momentum indicators to cycle indicators. When you analyze Bionano charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Bionano Genomics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Bionano Genomics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bionano Genomics based on widely used predictive technical indicators. In general, we focus on analyzing Bionano Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bionano Genomics's daily price indicators and compare them against related drivers, such as volume indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Bionano Genomics's intrinsic value. In addition to deriving basic predictive indicators for Bionano Genomics, we also check how macroeconomic factors affect Bionano Genomics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Payables Turnover1.451.742.563.27
Days Of Inventory On Hand320.5496.99314.71185.98
Hype
Prediction
LowEstimatedHigh
0.010.205.44
Details
Intrinsic
Valuation
LowRealHigh
0.173.488.72
Details
4 Analysts
Consensus
LowTargetHigh
12.0113.2014.65
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.25-0.25-0.25
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bionano Genomics. Your research has to be compared to or analyzed against Bionano Genomics' peers to derive any actionable benefits. When done correctly, Bionano Genomics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Bionano Genomics.

Learn to be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Global Correlations Now

   

Global Correlations

Find global opportunities by holding instruments from different markets
All  Next Launch Module

Bionano Genomics pair trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bionano Genomics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionano Genomics will appreciate offsetting losses from the drop in the long position's value.

Bionano Genomics Pair Trading

Bionano Genomics Pair Trading Analysis

The ability to find closely correlated positions to Bionano Genomics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bionano Genomics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bionano Genomics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bionano Genomics to buy it.
The correlation of Bionano Genomics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bionano Genomics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bionano Genomics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bionano Genomics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bionano Genomics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bionano Genomics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bionano Genomics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bionano Genomics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bionano Genomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Bionano Stock, please use our How to Invest in Bionano Genomics guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bionano Genomics. If investors know Bionano will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bionano Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.30)
Revenue Per Share
0.749
Quarterly Revenue Growth
(0.10)
Return On Assets
(0.33)
Return On Equity
(1.38)
The market value of Bionano Genomics is measured differently than its book value, which is the value of Bionano that is recorded on the company's balance sheet. Investors also form their own opinion of Bionano Genomics' value that differs from its market value or its book value, called intrinsic value, which is Bionano Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bionano Genomics' market value can be influenced by many factors that don't directly affect Bionano Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bionano Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bionano Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bionano Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.